FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and FDA takes first step in possible reversal of ban on some peptides The Washington Post The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences BPC 157: The Real Reason Why It's Not FDA Approved Stracuzzi Wellness